The endocannabinoid anandamide inhibits cholangiocarcinoma...

AJP Gastrointestinal and Liver Physiology 2008 / 10 Vol. 295; Iss. 6

The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway

DeMorrow, S., Francis, H., Gaudio, E., Venter, J., Franchitto, A., Kopriva, S., Onori, P., Mancinelli, R., Frampton, G., Coufal, M., Mitchell, B., Vaculin, B., Alpini, G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
295
Language:
english
Journal:
AJP: Gastrointestinal and Liver Physiology
DOI:
10.1152/ajpgi.90455.2008
Date:
October, 2008
File:
PDF, 1.11 MB
english, 2008
Conversion to is in progress
Conversion to is failed